Work with thought leaders and academic experts in anesthesiology pain medicine

Companies can greatly benefit from working with experts in the field of anesthesiology and pain medicine. These professionals bring a wealth of knowledge and experience that can contribute to various projects and initiatives. Here are five ways companies can collaborate with academic researchers in this field: 1. Research and Development: Anesthesiology and pain medicine experts can provide valuable insights and contribute to the development of new drugs, medical devices, and treatment protocols. 2. Clinical Trials: Companies conducting clinical trials can partner with these experts to design and oversee studies, ensuring the safety and efficacy of new treatments. 3. Pain Management Solutions: Academic researchers can help companies develop innovative pain management solutions, including non-pharmacological approaches and personalized treatment plans. 4. Education and Training: Collaborating with experts in anesthesiology and pain medicine can enhance the education and training programs offered by companies in the healthcare industry. 5. Consulting and Advisory Services: Companies can leverage the expertise of these thought leaders to provide consulting and advisory services, helping them make informed decisions and navigate complex challenges.

Experts on NotedSource with backgrounds in anesthesiology pain medicine include Daniel Milej, Ph.D., Luke Connelly, Professor Sinead McGilloway, Maham Zain, Mehrdad Sheikhvatan, Yayao Ma, and Bryan L Williams.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (53)
Health economics
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 48 more
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link]( process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Professor Sinead McGilloway

Professor of Family and Community Mental Health and Founder Director of the Centre for Mental Health and Community Research (CMHCR), Maynooth University Department of Psychology (THE 2023 ranking: 126-150) and Social Sciences Institute.
Most Relevant Research Interests
Other Research Interests (40)
Public Health, Environmental and Occupational Health
Health Policy
Sociology and Political Science
Social Sciences (miscellaneous)
And 35 more
Professor Sinead McGilloway is Professor of Family and Community Mental Health and Founder Director of the *Centre for Mental Health and Community Research* in the Maynooth University Dept of Psychology and Social Sciences Institute ([]( She is a Chartered Psychologist and Chartered Scientist with the British Psychological Society (BPS) and an Associate Fellow of the BPS. She has extensive experience in undertaking engaged policy- and practice-relevant research with a focus on child and adult mental health and well-being (incl. vulnerable/ marginalised groups), early intervention/prevention and service evaluation. She has won significant research funding to date, is widely published and has won a number of awards, including the Lionel Hersov Memorial (Team) Award by the (UK) Association for Child and Adolescent Mental Health (2022), an Irish Research Council Research Ally prize (2022) and Maynooth University Faculty of Social Sciences Research Achievement Award 2021.

Example anesthesiology pain medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on anesthesiology pain medicine?

Development of a New Pain Medication

An academic researcher in anesthesiology and pain medicine can collaborate with a pharmaceutical company to develop a new pain medication. Their expertise in pain management and understanding of the underlying mechanisms can contribute to the formulation and testing of the drug.

Improving Surgical Techniques

By partnering with anesthesiology and pain medicine experts, surgical equipment manufacturers can improve their products and develop new techniques that minimize pain and discomfort during and after surgery. This collaboration can lead to advancements in surgical procedures and better patient outcomes.

Designing Non-Pharmacological Pain Management Solutions

Companies specializing in non-pharmacological pain management can collaborate with academic researchers to design and develop innovative solutions. This can include techniques such as acupuncture, physical therapy, and cognitive-behavioral therapy, which can be integrated into comprehensive pain management programs.

Optimizing Anesthesia Delivery Systems

Medical device manufacturers can partner with anesthesiology experts to optimize anesthesia delivery systems. This collaboration can lead to the development of safer and more efficient devices, improving patient comfort and reducing the risk of complications during surgical procedures.

Enhancing Postoperative Pain Management

Collaborating with academic researchers in anesthesiology and pain medicine can help pharmaceutical companies develop new drugs and treatment protocols for postoperative pain management. This can lead to more effective pain relief options and improved recovery outcomes for patients.